Bayer Ebitda from 2010 to 2026

BAYA Stock  EUR 10.70  0.20  1.83%   
Bayer Aktiengesellscha's EBITDA is increasing over the last several years with slightly volatile swings. EBITDA is predicted to flatten to about 8.4 B. During the period from 2010 to 2026 Bayer Aktiengesellschaft EBITDA regressed destribution of quarterly values had mean deviationof  2,459,117,647 and mean square error of 13729509.4 T. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
15 B
Current Value
8.4 B
Quarterly Volatility
3.8 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Bayer Aktiengesellscha financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bayer Aktiengesellscha's main balance sheet or income statement drivers, such as Tax Provision of 181.3 M, Interest Income of 361.3 M or Discontinued Operations of 6.1 B, as well as many indicators such as . Bayer financial statements analysis is a perfect complement when working with Bayer Aktiengesellscha Valuation or Volatility modules.
  
This module can also supplement various Bayer Aktiengesellscha Technical models . Check out the analysis of Bayer Aktiengesellscha Correlation against competitors.
The Ebitda trend for Bayer Aktiengesellschaft offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Bayer Aktiengesellscha is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Bayer Aktiengesellscha's Ebitda Growth Pattern

Below is the plot of the Ebitda of Bayer Aktiengesellschaft over the last few years. It is Bayer Aktiengesellscha's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bayer Aktiengesellscha's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Bayer Ebitda Regression Statistics

Arithmetic Mean8,925,000,000
Coefficient Of Variation42.52
Mean Deviation2,459,117,647
Median8,108,000,000
Standard Deviation3,794,920,927
Sample Variance14401424.8T
Range17.4B
R-Value0.33
Mean Square Error13729509.4T
R-Squared0.11
Significance0.20
Slope244,949,755
Total Sum of Squares230422797.5T

Bayer Ebitda History

20268.4 B
202515 B
202213 B
20216.4 B
2020-2.4 B
201910.1 B
201810.3 B

About Bayer Aktiengesellscha Financial Statements

Bayer Aktiengesellscha stakeholders use historical fundamental indicators, such as Bayer Aktiengesellscha's Ebitda, to determine how well the company is positioned to perform in the future. Although Bayer Aktiengesellscha investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bayer Aktiengesellscha's assets and liabilities are reflected in the revenues and expenses on Bayer Aktiengesellscha's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bayer Aktiengesellschaft. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA15 B8.4 B

Currently Active Assets on Macroaxis

Other Information on Investing in Bayer Stock

Bayer Aktiengesellscha financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer Aktiengesellscha security.